Propel Bio Management as of Sept. 30, 2024
Portfolio Holdings for Propel Bio Management
Propel Bio Management holds 21 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Applied Therapeutics Comm (APLT) | 32.4 | $56M | 6.6M | 8.50 | |
| Plains Gp Holdings Lp-cl Comm (PAGP) | 13.7 | $24M | 1.3M | 18.50 | |
| Phathom Pharmaceuticals I Comm (PHAT) | 9.1 | $16M | 870k | 18.08 | |
| Achieve Life Sciences Comm (ACHV) | 6.7 | $12M | 2.5M | 4.74 | |
| Tscan Therapeutics Comm (TCRX) | 6.0 | $10M | 2.1M | 4.98 | |
| Akero Therapeutics Comm (AKRO) | 5.7 | $9.9M | 344k | 28.69 | |
| Madrigal Pharmaceuticals Comm (MDGL) | 5.3 | $9.1M | 43k | 212.22 | |
| Avidity Biosciences Comm (RNA) | 4.8 | $8.2M | 179k | 45.93 | |
| Ardelyx Comm (ARDX) | 4.3 | $7.4M | 1.1M | 6.89 | |
| Telesat Corp Comm (TSAT) | 2.8 | $4.8M | 366k | 13.17 | |
| Abeona Therapeutics Comm (ABEO) | 2.3 | $3.9M | 624k | 6.32 | |
| Kymera Therapeutics Comm (KYMR) | 1.5 | $2.7M | 56k | 47.33 | |
| Syndax Pharmaceuticals In Comm (SNDX) | 1.5 | $2.6M | 133k | 19.25 | |
| Kura Oncology Comm (KURA) | 1.5 | $2.5M | 130k | 19.54 | |
| Zevra Therapeutics Comm (ZVRA) | 0.7 | $1.2M | 180k | 6.94 | |
| Eiger Biopharmaceuticals Comm | 0.7 | $1.2M | 146k | 8.50 | |
| Athira Pharma Comm (ATHA) | 0.4 | $666k | 1.5M | 0.45 | |
| Compass Pathways Comm (CMPS) | 0.3 | $504k | 80k | 6.30 | |
| Verrica Pharmaceuticals I Comm | 0.3 | $500k | 345k | 1.45 | |
| Maat Pharma Saca Comm (MATPF) | 0.0 | $18k | 2.4k | 7.42 | |
| Chinook Therapeutics Comm | 0.0 | $9.8k | 79k | 0.12 |
